Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-05-03 @ 11:02 PM
Study NCT ID:
NCT04354402
Status:
COMPLETED
Last Update Posted:
2023-04-18
First Post:
2020-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL
Sponsor:
SymBio Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2019001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None